Аspirin slows down mental decline in the elderly

Using long-term acetilsalixylic acid (the active ingredient of aspirin), low doses have the effect of slowing down the intellectual decline of older women. That is the conclusion of researchers from Gotenborg University, Sweden, after 5 years of monitoring the mental and physical health of 681 elderly women aged 70 to 92.

The work is published in the British Medical Journal Open.

All women in the monitoring area were in the high risk group for cardiovascular disease. Of these, 129 in five years were prevented from the above diseases by taking 4 aspirin tablets daily. All instruments are regularly examined for health as well as intellectual tests.

Picture 1 of Аspirin slows down mental decline in the elderly
Specific effects of aspirin on the brain still need further research.

After 5 years, all the instruments showed signs of memory impairment and thinking ability, but aspirin tools had a lower level of decline than the others. That effect of aspirin is not affected by age and other genetic factors.

According to one of the authors of the study Silke Kern, it is still early to conclude that asprin has a good effect on brain function, because the experiment has few participants (only 129 instruments).

'We can only comment that acetilsalyxilic acid protects the brain from deterioration due to aging, in particular, the risk of cardiovascular disease is high for some women. We have not yet figured out whether this treatment has any consequences, ' Kern told reporter EurekAlert !. The study authors embarked on a program to observe the next 5-year cycle on the effects of aspirin on the health of the elderly.

Please note that in 2007 also in the British Medical Journal published a summary of studies in 10 years involving more than 6,000 American women over 65 years of age, including not finding work. Use of aspirin for daily use in low doses for confusion.

Meanwhile, the summary still emphasizes the effectiveness of acetilsalyxylic acid in preventing cancer and cardiovascular diseases.